BACE1 and Alzheimer disease: We demonstrated in this study that radiolabeled RmAb158-scFv8D3 is able to quantify changes in brain Aβ levels after BACE-1 inhibition in 2 AD mouse models, and further, that the readout is different from that of 11C-PiB.